Quality of life assessment of cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial

Title
Quality of life assessment of cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial
Authors
Keywords
Cabozantinib, Carcinoma, Hepatocellular, Liver neoplasms, Patient health questionnaire, Patient Reported Outcome Measures, Quality-adjusted life years, Visual analog scale
Journal
EUROPEAN JOURNAL OF CANCER
Volume 168, Issue -, Pages 91-98
Publisher
Elsevier BV
Online
2022-04-27
DOI
10.1016/j.ejca.2022.03.021

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started